The yield is strong. The rooms are full. Run it through the calculator and the coverage looks comfortable. Then the lender says no – and nobody can quite explain why.
This happens more often than most property investors expect. And the reason is almost never the income. Lenders are not assessing whether the deal makes money. They are assessing whether the asset is financeable, whether the compliance holds up under scrutiny, and whether the valuation supports what the investor is paying.
Those are three completely different questions. And any one of them can kill a deal that looks perfectly fine on paper. If you are looking at HMO finance for the first time, understanding where lenders actually draw the line is the most useful thing you can do before a deal goes in.
A bathroom layout that works in practice may still fail a lender’s compliance check during HMO finance underwriting
Why HMOs Seem Simple at First
On paper, the case for HMO investment is hard to argue with.
Multiple income streams from a single asset. Rental coverage that sits well above what most lenders require on a standard buy-to-let. Voids in one room do not stop the mortgage being paid – the others keep covering it. Run the numbers and the deal looks more resilient than a single let, not less.
This is why investors come to the table expecting a straightforward conversation. The income is there. The coverage is comfortable. The logic seems sound.
The problem is that lenders are not following the same logic. They are not asking whether the deal makes money. They are asking whether the asset is something they can lend against, value accurately, and if necessary, sell. Those questions take them somewhere completely different – and that is where the friction starts.
Where Lenders Start to Push Back
This is where deals that looked clean start to get complicated.
Licensing is usually the first thing that causes a problem. A property operating as an HMO without confirmed licensing in place – or with an application still pending – puts a lender in an uncomfortable position. Some will wait. Some will not proceed at all until the licence is confirmed. An investor who assumed this would be sorted during the process can find themselves stuck with a lender who will not move forward until it is.
Layout and configuration cause more problems than most investors expect. Room sizes that fall below the minimum thresholds, awkward access arrangements, inadequate separation between shared and private spaces – these are not just planning issues. They are valuation issues. A room a surveyor cannot comfortably classify as a lettable bedroom is a room that does not contribute to the income assessment. Lose two rooms that way and the deal can unravel quickly.
Property type matters in ways that are not always obvious upfront. Flats above commercial premises, buildings with unclear planning histories, non-standard construction – these attract a narrower pool of lenders regardless of how the income looks. Some lenders simply will not touch certain asset types. Others will, but at worse terms.
Location is the factor investors most consistently underestimate. Some councils are actively restricting HMO growth through Article 4 directions. Lenders are aware of this – a property in an area where further HMO licences are being refused creates a resale problem – and lenders think about resale even when investors do not. For more on how the regulatory environment is affecting lender appetite, how HMO mortgage challenges in the UK have increased under tightened rental rules in detail.
Valuation Differences
This is the part that catches experienced investors out – not just beginners.
The way an investor values an HMO and the way a lender’s surveyor values it are often two completely different calculations. The investor is looking at income. The surveyor is looking at comparable sales. And in most areas, the comparable sales are family homes – not HMOs.
That gap matters enormously. An investor running a yield-based calculation might arrive at a figure of £450,000 for a well-performing seven-bedroom HMO. The surveyor looks at what three-bedroom and four-bedroom houses on the same street have sold for, finds no meaningful HMO comparables, and comes back at £340,000. The lender bases the loan on the surveyor’s number.
Suddenly the loan-to-value is wrong. The deposit required has increased. The deal the investor agreed to buy no longer works under the structure they had in place.
This is not the surveyor being difficult. It is the surveyor doing their job within the constraints they are given. In areas without a deep HMO transaction history, income-based valuation carries very little weight. The market evidence simply is not there to support it.
Investors who price a deal on yield and assume the valuation will follow are taking a risk that does not show up in the spreadsheet – until the survey comes back. For a full breakdown of the assessment process, how lenders assess HMO mortgage applications covers what underwriters are actually looking for.
Common Reasons HMOs Get Declined
Most declined HMO applications do not fail because of one catastrophic problem. They fail because several smaller issues land on the same application at the same time – and the cumulative picture is too uncomfortable for the lender to proceed.
Licensing gaps are the most common single factor. Not necessarily a property that has never been licensed, but one where the paperwork is incomplete, out of date, or still in progress at the point of application. Lenders do not like uncertainty they cannot resolve before offer.
Room sizes come up consistently. Properties that work perfectly well as HMOs in practice – tenants happy, rooms full – can still fall down because one or two rooms sit below the minimum dimensions a surveyor will accept. Those rooms drop out of the income calculation and the deal changes shape.
Projected rents are another recurring problem. An investor who has modelled the deal on what the market might one day support rather than what tenants are currently paying is building on an assumption. Lenders want evidence, not projections. The further the rent roll is from confirmed tenancy agreements, the more it gets discounted.
Then there is borrower experience. Underwriters look at the person behind the application as well as the property in front of them. Someone with no HMO track record applying for finance on a sizeable or complicated asset is a harder case to place – not impossible, but appetite, rate and terms all shift.
These issues rarely arrive alone. When they stack up, the risk profile becomes one the lender cannot work with. For detail on how lenders stress test the numbers on more complex deals, debt servicing ratios in complex HMO finance deals is worth reading before you structure an application.
When the Numbers Work and the Deal Still Fails
Mark has been investing in buy-to-let for six years. Two single lets, both performing well. He finds a seven-bedroom HMO in a university town – fully tenanted, strong rent roll, management already in place. The gross yield looks exceptional. He runs the numbers three different ways and the coverage is comfortable on all of them.
He approaches a lender with a solid HMO track record and puts in the application.
The surveyor visits. The report comes back and it has three issues.
Two of the bedrooms measure below the minimum room size thresholds. Not by much – but enough. The HMO licence is confirmed but only recently renewed, and one condition attached to it has not yet been signed off by the council. And in terms of comparable sales evidence, there is almost nothing – the surrounding streets are family housing, and the few HMO sales the surveyor can find are too different in size and configuration to carry much weight.
The valuation comes in at £55,000 below the agreed purchase price.
The lender is now looking at a different deal. The loan-to-value has moved. The licensing condition introduces uncertainty they cannot ignore. The room sizes mean two bedrooms cannot be fully counted in the income assessment.
Each issue is manageable on its own. Together they push the application outside what the lender can approve.
Mark’s numbers still work. The property still performs. But the lender is not financing a spreadsheet – and that is the gap nobody warned him about.
How to Structure an HMO So It Works
The deals that go through are not always the ones with the best numbers. They are the ones where the lender’s questions have already been answered before anyone asks them.
Licensing needs to be confirmed before the application goes in – not in progress, not expected imminently, confirmed. A pending licence introduces uncertainty a lender cannot price. It becomes a condition, a delay, or a reason to decline. Get it resolved first and remove that variable entirely.
Room sizes trip people up more consistently than almost anything else. If any room sits close to the minimum threshold, get clarity on whether a surveyor will accept it before you commit to the purchase price. Losing a bedroom during underwriting is not a minor adjustment – it changes the income assessment, the valuation and potentially the whole deal structure.
Know your local authority’s position on HMOs before you buy. If the council is actively restricting new licences or has Article 4 directions in place, lenders will build that directly into their appetite. It affects resale, it affects licensing risk, and it affects what terms are available. Some lenders will not touch certain areas regardless of how the income looks.
Be conservative on valuation from the start. If the area lacks HMO comparable sales evidence, build that into your numbers. Do not price the deal on what an income-based valuation should produce and then hope the surveyor agrees. In areas without evidence, they usually will not.
Borrower profile matters. If you are new to HMOs, start with properties that are fully licensed, compliant and well evidenced – assets where nothing needs explaining. Build the track record first. Lenders become significantly more flexible once they can see you have managed this type of asset successfully before.
The investors who struggle with HMO mortgages are usually not purchasing bad assets. They are purchasing assets that are not ready to finance yet – and that is a problem preparation can solve.
Conclusion
HMOs can still produce strong yields and back a solid long-term investment strategy. The issue is not the asset class – it is the gap between how investors assess a deal and how lenders do.
The income can work. The yield can be exceptional. And the lender can still say no – not because the deal is bad, but because the asset does not meet what they need to lend against it confidently. Licensing, room sizes, valuation evidence, local authority position, borrower track record – any one of these can move a decision. When several arrive together, the application rarely survives.
The investors who place HMO finance successfully are not necessarily sourcing better properties. They are preparing more thoroughly. Compliance locked in before approach. Valuations stress-tested against realistic comparables. Lenders chosen based on their actual appetite for the asset rather than their headline rates alone.
That groundwork is what determines whether an application completes or falls apart in underwriting – usually weeks after everyone assumed it was going to be fine.
FAQs
Why do HMOs get declined even when the rental income looks strong?
Because the income is not what the lender is worried about.
The yield was never the problem. What kills these deals is what sits behind the numbers – a licence that is not quite confirmed, rooms a surveyor will not count, a valuation that comes back £50,000 light. Any one of those can override a perfectly healthy rent roll. When they arrive together, the income figure stops mattering entirely.
How does valuation affect HMO finance?
It can pull the whole deal apart – and it usually arrives as a surprise.
Investors price HMOs on yield. Surveyors price them on comparable sales – and in most areas those are family homes, not HMOs. That gap comes straight off the loan and the deal the investor agreed to buy no longer fits the structure they had in place. For more on how lenders categorise HMO assets and where the valuation approach differs, HMO lending – residential or commercial finance explains the distinction clearly.
Does licensing status really affect mortgage approval?
More than almost anything else – and it catches people out constantly.
Not necessarily a property that has never been licensed. Often it is one where the paperwork is mostly there but not quite complete – a condition outstanding, a renewal still being processed. That is enough. Lenders cannot make a formal offer against an uncertain licensing position. Some will wait. Most will not.
Do room sizes matter to HMO lenders?
Put it this way – one undersized bedroom can unravel a deal that looked solid for months.
It is not the surveyor being difficult. A room below the minimum threshold simply cannot be counted as a lettable bedroom. It drops out of the income calculation. Lose two rooms that way and suddenly the affordability does not work, the valuation shifts, and the structure the investor built the whole deal around no longer holds together.
Is HMO finance harder to get than a standard buy-to-let mortgage?
Harder is the wrong word. Less forgiving is closer to the truth.
On a single let, one thing goes wrong and you can usually work around it. On an HMO, licensing, room sizes, valuation, local authority policy and your own track record all land on the same application at the same time. The lender is comfortable when all of them are fine. When two or three are slightly off, there is nowhere to hide – and deals that felt certain three weeks ago stop moving forward.
Does my experience as an investor affect HMO mortgage approval?
Significantly – and this is the one people most consistently underestimate.
A lender looking at someone with no HMO history applying for finance on a six or seven bedroom property in an Article 4 area is looking at a lot of unknowns at once. They cannot rely on track record to offset the complexity of the asset. That uncertainty feeds directly into the decision – sometimes it means worse terms, sometimes it means no appetite at all. Starting smaller is not just sensible advice. For some lenders it is the only path in.
What is an Article 4 direction and why do lenders care about it?
It is a council restriction on HMO growth – and lenders treat it as a resale risk.
In areas with Article 4 in place, converting a property to an HMO requires planning permission rather than just a licence. Some councils are actively refusing new applications. Lenders are aware of this because it affects what happens if they ever need to sell the asset. A property that cannot easily be re-licensed or sold on as an HMO in a restricted area is a harder asset to lend against – regardless of how it is performing right now.
Should I get a valuation before approaching a lender for HMO finance?
If the area lacks HMO comparable sales, yes – and it could save you a lot of wasted time.
The number an investor arrives at using yield and projected income is often very different to what a surveyor will support using comparable sales evidence. Finding that gap out after an application has been submitted – with legal costs running and a completion date in the diary – is a painful and expensive way to discover the deal does not stack up. An independent valuation upfront removes that uncertainty before it becomes a problem.
The documents a lender’s underwriter reviews tell a different story to the one an investor’s spreadsheet tells
Talk to a Broker Who Knows Where HMO Deals Actually Fall Apart
Most HMO applications that get declined were not bad deals. They were deals that went to the wrong lender, with the wrong structure, before the compliance was properly in place.
At Commercial Finance Network we work with HMO investors at every stage – from initial deal assessment through to finance placement. We know which lenders have genuine appetite for complex HMO assets, how they assess licensing and room configuration, and how to structure an application that survives underwriting rather than stalling in it.
If you are looking at either an HMO remortgage or new purchase and want to understand how a lender will actually view it before anything goes in, speak to us first.
Call: 03303 112 646
Email: [email protected]
Commercial Finance Network is an independent commercial finance broker authorised and regulated by the Financial Conduct Authority.